Gilbert: Obtained 1 invention patent.

Gebel Announcement: The company has recently received an invention patent certificate issued by the National Intellectual Property Office. The patent is titled "Crystalline form C of a paclitaxel compound hydrate and its preparation method and application," with an application date of October 9, 2022, and a publication date of June 12, 2026. The patentee is Jiangsu Gebel Pharmaceutical Co., Ltd., and the patent expires after 20 years. This patent has the advantages of high solubility in water, good solid-state physical and chemical stability, and good bioavailability. It is a reflection and extension of the company's core technology, and it is beneficial for improving the intellectual property protection system and promoting technological innovation, but it will not have a significant impact on the company's recent operations.